MedPath

Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus

Not Applicable
Not yet recruiting
Conditions
Clinical Study
Interventions
Behavioral: personalized chronoprevention
Registration Number
NCT05645419
Lead Sponsor
University Medical Center, Kazakhstan
Brief Summary

Purpose: To develop a mathematical model for the occurrence of MI in patients with T2D by studying the relationship between the internal personalized biorhythms of the patients and the external transit rhythms of space objects; to develop and implement a personalized method of chrono-prevention of MI in patients with T2D.

Obejectives:

1.1 To investigate patterns of the influence of external transit rhythms of space objects on the occurrence of MI in patients with T2D: an observational study using clinical databases.

1.2 To investigate patterns of influence of cyclic activity of helio- and geophysical phenomena in the interplanetary medium on the occurrence of MI in patients with T2D.

2. Develop a mathematical model for predicting the occurrence of MI in patients with T2D, based on the identification of the relationship patterns between the internal personalized biorhythms of these patients and the external transit rhythms of space objects.

3. To investigate the effectiveness of the mathematical model for predicting the occurrence of MI in patients with T2D for the purpose of personalized chrono-prevention: a randomized clinical trial.

Detailed Description

Participants and study design.

1. Study of the influence of external transit rhythms of space objects, as well as the cyclic activity of helio- and geophysical phenomena in the interplanetary medium on the occurrence of MI in patients with T2D combining population based and clinical data.

For a retrospective population study, all patients aged 30-65 years with T2D (MI+/-) from the republican database of the Ministry of Health of the Republic of Kazakhstan (MoH) over the past 10 years will be included.

For a prospective population trial ≥150 patients aged 30-65 years with T2D (MI+/-) will be included.

2. Mathematical and statistical analysis of the collected chrono-geo-biological and clinical data and data on the relationship between the internal personalized biorhythms of the patients and the external transit rhythms of space objects with the definition of "critical periods" as well as the cyclic activity of helio- and geophysical phenomena in the interplanetary medium. Study duration: 12-24 weeks.

3. Study of the effectiveness of the developed mathematical model for predicting the occurrence of MI in patients with T2D in a pilot prospective randomized clinical trial (personalized chronoprophylaxis). The study will include at least 60 patients aged 30-65 years of both sexes with moderate T2D: 1) the main group (n≥30), where patients with T2D will additionally receive personalized chronoprevention intervention; 2) the control group (n≥30), where patients with T2D will only be under observation.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patients aged 30-65 years of both sexes
  • severe-to-moderate subcompensated stage of T2D without MI
  • decompensated stage of T2D without MI
Exclusion Criteria
  • compensated stage of T2D without MI
  • patients with T2D and with MI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
personalized chronopreventionpersonalized chronopreventionthe main group (n=30), where patients with T2D, in addition to their traditional prescriptions, will receive the intervention method of personalized chronoprevention
Primary Outcome Measures
NameTimeMethod
Number of Participants with myocardial infarction24 weeks

occurence of myocardial infarction

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kuat Pernekulovich Oshakbayev

🇰🇿

Astana, Kazakhstan

© Copyright 2025. All Rights Reserved by MedPath